ACCME Presents at Fifth Annual PACME Summit

May 31, 2012
Posted by: 
Tamar Hosansky

Murray Kopelow, MD, ACCME Chief Executive, gave a presentation at the Alliance for Continuing Education in the Health Professions' Fifth Annual PACME Summit, held in April in Jersey City. (PACME is the Pharmaceutical Alliance for CME.) Dr. Kopelow discussed the role of accredited continuing education as a strategic asset to the Food and Drug Administration's Risk Evaluation and Mitigation Strategy (REMS) for long-acting and extended-release opioids. He explained that the ACCME’s role was to offer information regarding compliance with ACCME requirements. Using case examples, Dr. Kopelow explained that accredited providers must comply with the Standards for Commercial Support when developing CME that addresses REMS.

Information and resources about REMS and CME are available here: